APA (7th ed.) Citation
(2026). Risk of venous thromboembolism with CDK4/6 inhibitor use in breast cancer: A systematic review and meta-analysis. The Oncologist.
Chicago Style (17th ed.) Citation
"Risk of Venous Thromboembolism with CDK4/6 Inhibitor Use in Breast Cancer: A Systematic Review and Meta-analysis." The Oncologist 2026.
MLA (9th ed.) Citation
"Risk of Venous Thromboembolism with CDK4/6 Inhibitor Use in Breast Cancer: A Systematic Review and Meta-analysis." The Oncologist, 2026.
Warning: These citations may not always be 100% accurate.